1	Paciente	paciente	NCCS000	C0030705	persona	0-8	427_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
2	diagnosticado	diagnosticar	VMP00SM	-	-	9-22	427_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
3	de	de	SPS00	C0332285	atributo	23-25	427_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
4	diverticulitis	diverticulitis	NC00SC0	C0012813	trastorno#anomalía_morfológica	26-40	427_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
5	aguda	agudo	AQ0FS0	C0205178	calificador	41-46	427_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	4	1018	Modif
6	,	,	Fc	-	-	46-47	427_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
7	tratado	tratar	VMP00SM	C0332293_1	atributo_1	48-55	427_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
8	con	con	SPS00	C0332293_2	atributo_2	56-59	427_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
9	amoxicilina	amoxicilina	NC00SC0	C0002645#C0521900	sustancia	60-71	427_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-	-	-	-
10	/	/	Fh	-	-	71-72	427_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
11	clavulánico	clavulánico	NCMS000	-	-	72-83	427_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-	-	-	-
12	.	.	Fp	-	-	83-84	427_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-

1	Al	al	SP+DA	-	-	85-87	427_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
2	cabo	cabo	NCMS000	-	-	88-92	427_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
3	de	de	SPS00	C0332285	atributo	93-95	427_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
4	5	5	Z	-	-	96-97	427_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
5	días	d	NCMP000	-	-	98-102	427_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
6	comienza	comenzar	VMIP3S0	-	-	103-111	427_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
7	con	con	SPS00	C0332287	atributo	112-115	427_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
8	fiebre	fiebre	NCFS000	C0015967	hallazgo	116-122	427_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-	-	-	-
9	y	y	CC	C1706368	calificador	123-124	427_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
10	diarrea	diarrea	NCFS000	C0011991	hallazgo	125-132	427_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-	-	-	-
11	.	.	Fp	-	-	132-133	427_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-

1	Se	se	P00CN000	-	-	134-136	427_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
2	le	le	PP3CSD00	C1292157#C0409974	hallazgo#trastorno	137-139	427_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
3	diagnostica	diagnosticar	VMIP3S0	-	-	140-151	427_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
4	de	de	SPS00	C0332285	atributo	152-154	427_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
5	colitis	colitis	NCFN000	C0238106_1	trastorno_1	155-162	427_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-	-	-	-
6	por	por	SPS00	C0238106_2	trastorno_2	163-166	427_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
7	Clostridium	Clostridium		C0238106_3	trastorno_3	167-178	427_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-	5	1020	Causada_por
8	difficile	difficile		C0238106_4	trastorno_4	179-188	427_QUEST_clinical_caseMIR	SENT3	I-Grp_Enfermedad	-	7	50	MultiE
9	,	,	Fc	-	-	188-189	427_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
10	se	se	P00CN000	-	-	190-192	427_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
11	suspende	suspender	VMIP3S0	-	-	193-201	427_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
12	la	el	DA0FS0	-	-	202-204	427_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
13	amoxicilina	amoxicilina	NC00SC0	C0002645#C0521900	sustancia	205-216	427_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-	-	-	-
14	/	/	Fh	-	-	216-217	427_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
15	clavulánico	clavulánico	AQ0MS00	-	-	217-228	427_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-	-	-	-
16	y	y	CC	C1706368	calificador	229-230	427_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
17	se	se	P00CN000	-	-	231-233	427_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
18	pauta	pautar	VMIP3S0	-	-	234-239	427_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
19	metronidazol	metronidazol	NC00SC0	C0025872	sustancia	240-252	427_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-	-	-	-
20	.	.	Fp	-	-	252-253	427_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-

1	A	a	SPS00	-	-	254-255	427_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
2	los	el	DA0MP0	-	-	256-259	427_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
3	4	4	Z	-	-	260-261	427_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
4	días	d	NCMP000	-	-	262-266	427_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
5	no	no	RN	C1298908	calificador	267-269	427_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
6	ha	haber	VAIP3S0	-	-	270-272	427_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
7	respondido	responder	VMP00SM	-	-	273-283	427_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
8	al	al	SP+DA	-	-	284-286	427_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
9	metronidazol	metronidazol	NC00SC0	C0025872	sustancia	287-299	427_QUEST_clinical_caseMIR	SENT4	B-Grp_Medicamento	-	-	-	-
10	,	,	Fc	-	-	299-300	427_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
11	pero	pero	CC	-	-	301-305	427_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
12	se	se	P00CN000	-	-	306-308	427_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
13	encuentra	encontrar	VMIP3S0	-	-	309-318	427_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
14	clínicamente	clínicamente	RG	-	-	319-331	427_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
15	estable	estable	AQ0CS0	C0205360	calificador	332-339	427_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
16	.	.	Fp	-	-	339-340	427_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-

1	El	el	DA0MS0	-	-	341-343	427_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
2	siguiente	siguiente	AQ0CS0	C0332282	atributo	344-353	427_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
3	paso	paso	NCMS000	C1261552	calificador	354-358	427_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
4	del	del	SP+DA	-	-	359-362	427_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
5	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	363-374	427_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
6	es	ser	VSIP3S0	-	-	375-377	427_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
7	:	:	Fd	-	-	377-378	427_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
8	.	.	Fp	-	-	378-379	427_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-

